Paradoxical reactions in patients with tuberculous lymphadenitis: A pilot immunopathogenic study

Read full text Summarise with VIRAT
Authors: Akhil Rajendra, Gnanadurai John Fletcher, John Paul Demosthenes, Premkumar Thangavelu, Ben Chirag Ghale, Rajesh Kannangai, Mayur S. Ramesh, Priscilla Rupali
Cited by: 0
References: 23

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

OBJECTIVES: Paradoxical reactions (PRs) in HIV-negative tuberculosis is not well understood. This study aimed to determine the incidence and clinical and immunological predictors of PRs. METHODS: Patients with tuberculous lymphadenitis on anti-tuberculous therapy were monitored for PR. Clinical, histopathological, microbiological, and immunological parameters of PR (n = 10) and no PR (n = 66) groups were analyzed at baseline, 2 months, and 6 months. Peripheral blood mononuclear cells from patients with PR (n = 9) and no PR (n = 13) were stimulated with TB-ESAT peptide, and messenger RNA (mRNA) expressions of cytokines (interleukin [IL]-4, IL-10, IL-12, tumor necrosis factor [TNF]-α, interferon [IFN]-γ), and transcription factors (T-bet, GATA-3) were quantified. RESULTS: PR incidence was 5.7% (four of 70); six patients presented with PR at baseline. The mean PR onset was 3.25 months. The absence of necrosis at baseline was protective (odds ratio: 0.069; P = 0.039). IL-10 mRNA at 2 months and IL-12 mRNA at 6 months increased in the PR compared with the no PR group (P = 0.05). In the PR group, only baseline T-bet mRNA correlated with IFN-γ (r = 0.79, P

Fields of Study & Subjects

Tuberculosis Research and Epidemiology Diagnosis and treatment of tuberculosis Infectious Diseases and Tuberculosis

Publication details

Journal / source
International Journal of Infectious Diseases
Volume
167
Pages
108542–108542
Publication date
19 March 2026
Language
EN